Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

R337H mutation of the TP53 gene as a clinical marker in cancer patients: a systematic review of literature.

Genetics and molecular research : GMR - 16 Dec 2015

Borges L M, Ayres F M

Abstract excerpt

The germline R337H mutation of the TP53 gene has been associated with the development of many tumor types. This systematic review of literature investigated the association between the R337H mutation and the patients' family history and its predictive and prognostic value in cancer. Data were collected from articles archived in the PubMed, LILACS, MEDLINE, IBECS, and SciELO databases. The systematic review of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Biomarkers, Tumor
Share to Codon

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, p53

Share to Germ-Line Mutation

Share to Li-Fraumeni Syndrome

Share to Neoplasms

Share to Odds Ratio

Source

Identifiers

PMID: 26681051
DOI: 10.4238/2015.December.16.4

Genes

TP53

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

R337H mutation of the TP53 gene as a clinical marker in cancer patients: a systematic review of literature.PMID 26681051Read ↗

What 20 years of research has taught us about the TP53 p.R337H mutation.Semantic proximity Read ↗

The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.Semantic proximity Read ↗

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis.Semantic proximity Read ↗

Association of the germline TP53 R337H mutation with breast cancer in southern Brazil.Semantic proximity Read ↗

Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening?Semantic proximity Read ↗

Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil.Semantic proximity Read ↗

The R337H mutation in TP53 and breast cancer in BrazilSemantic proximity Read ↗

The Inherited p53 Mutation in the Brazilian Population.Semantic proximity Read ↗

Tumor Spectrum and Temporal Cancer Trends in adult carriers of Li-Fraumeni syndrome: Implications for Personalized Screening Strategies in<i>TP53</i>R337H carriersSemantic proximity Read ↗

Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect.Semantic proximity Read ↗

Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in BrazilSemantic proximity Read ↗

Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.